Cargando…

Reverse Onco-Cardiology: What Is the Evidence for Breast Cancer? A Systematic Review of the Literature

Breast cancer and cardiovascular diseases (CVD) represent significant global health challenges, with CVD being the leading cause of mortality and breast cancer, showing a complex pattern of incidence and mortality. We explore the intricate interplay between these two seemingly distinct medical condi...

Descripción completa

Detalles Bibliográficos
Autores principales: Boutas, Ioannis, Kontogeorgi, Adamantia, Kalantaridou, Sophia N., Dimitrakakis, Constantine, Patsios, Panagiotis, Kalantzi, Maria, Xanthos, Theodoros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671526/
https://www.ncbi.nlm.nih.gov/pubmed/38003690
http://dx.doi.org/10.3390/ijms242216500
_version_ 1785149426874974208
author Boutas, Ioannis
Kontogeorgi, Adamantia
Kalantaridou, Sophia N.
Dimitrakakis, Constantine
Patsios, Panagiotis
Kalantzi, Maria
Xanthos, Theodoros
author_facet Boutas, Ioannis
Kontogeorgi, Adamantia
Kalantaridou, Sophia N.
Dimitrakakis, Constantine
Patsios, Panagiotis
Kalantzi, Maria
Xanthos, Theodoros
author_sort Boutas, Ioannis
collection PubMed
description Breast cancer and cardiovascular diseases (CVD) represent significant global health challenges, with CVD being the leading cause of mortality and breast cancer, showing a complex pattern of incidence and mortality. We explore the intricate interplay between these two seemingly distinct medical conditions, shedding light on their shared risk factors and potential pathophysiological connections. A specific connection between hypertension (HTN), atrial fibrillation (AF), myocardial infarction (MI), and breast cancer was evaluated. HTN is explored in detail, emphasizing the role of aging, menopause, insulin resistance, and obesity as common factors linking HTN and breast cancer. Moreover, an attempt is made to identify the potential impact of antihypertensive medications and highlight the increased risk of breast cancer among those women, with a focus on potential mechanisms. A summary of key findings underscores the need for a multisystem approach to understanding the relationship between CVD and breast cancer is also explored with a highlight for all the gaps in current research, such as the lack of clinical observational data on MI and breast cancer in humans and the need for studies specifically designed for breast cancer. This paper concludes that there should be a focus on potential clinical applications of further investigation in this field, including personalized prevention and screening strategies for women at risk. Overall, the authors attempt to provide a comprehensive overview of the intricate connections between breast cancer and cardiovascular diseases, emphasizing the importance of further research in this evolving field of cardio-oncology.
format Online
Article
Text
id pubmed-10671526
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106715262023-11-19 Reverse Onco-Cardiology: What Is the Evidence for Breast Cancer? A Systematic Review of the Literature Boutas, Ioannis Kontogeorgi, Adamantia Kalantaridou, Sophia N. Dimitrakakis, Constantine Patsios, Panagiotis Kalantzi, Maria Xanthos, Theodoros Int J Mol Sci Review Breast cancer and cardiovascular diseases (CVD) represent significant global health challenges, with CVD being the leading cause of mortality and breast cancer, showing a complex pattern of incidence and mortality. We explore the intricate interplay between these two seemingly distinct medical conditions, shedding light on their shared risk factors and potential pathophysiological connections. A specific connection between hypertension (HTN), atrial fibrillation (AF), myocardial infarction (MI), and breast cancer was evaluated. HTN is explored in detail, emphasizing the role of aging, menopause, insulin resistance, and obesity as common factors linking HTN and breast cancer. Moreover, an attempt is made to identify the potential impact of antihypertensive medications and highlight the increased risk of breast cancer among those women, with a focus on potential mechanisms. A summary of key findings underscores the need for a multisystem approach to understanding the relationship between CVD and breast cancer is also explored with a highlight for all the gaps in current research, such as the lack of clinical observational data on MI and breast cancer in humans and the need for studies specifically designed for breast cancer. This paper concludes that there should be a focus on potential clinical applications of further investigation in this field, including personalized prevention and screening strategies for women at risk. Overall, the authors attempt to provide a comprehensive overview of the intricate connections between breast cancer and cardiovascular diseases, emphasizing the importance of further research in this evolving field of cardio-oncology. MDPI 2023-11-19 /pmc/articles/PMC10671526/ /pubmed/38003690 http://dx.doi.org/10.3390/ijms242216500 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Boutas, Ioannis
Kontogeorgi, Adamantia
Kalantaridou, Sophia N.
Dimitrakakis, Constantine
Patsios, Panagiotis
Kalantzi, Maria
Xanthos, Theodoros
Reverse Onco-Cardiology: What Is the Evidence for Breast Cancer? A Systematic Review of the Literature
title Reverse Onco-Cardiology: What Is the Evidence for Breast Cancer? A Systematic Review of the Literature
title_full Reverse Onco-Cardiology: What Is the Evidence for Breast Cancer? A Systematic Review of the Literature
title_fullStr Reverse Onco-Cardiology: What Is the Evidence for Breast Cancer? A Systematic Review of the Literature
title_full_unstemmed Reverse Onco-Cardiology: What Is the Evidence for Breast Cancer? A Systematic Review of the Literature
title_short Reverse Onco-Cardiology: What Is the Evidence for Breast Cancer? A Systematic Review of the Literature
title_sort reverse onco-cardiology: what is the evidence for breast cancer? a systematic review of the literature
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671526/
https://www.ncbi.nlm.nih.gov/pubmed/38003690
http://dx.doi.org/10.3390/ijms242216500
work_keys_str_mv AT boutasioannis reverseoncocardiologywhatistheevidenceforbreastcancerasystematicreviewoftheliterature
AT kontogeorgiadamantia reverseoncocardiologywhatistheevidenceforbreastcancerasystematicreviewoftheliterature
AT kalantaridousophian reverseoncocardiologywhatistheevidenceforbreastcancerasystematicreviewoftheliterature
AT dimitrakakisconstantine reverseoncocardiologywhatistheevidenceforbreastcancerasystematicreviewoftheliterature
AT patsiospanagiotis reverseoncocardiologywhatistheevidenceforbreastcancerasystematicreviewoftheliterature
AT kalantzimaria reverseoncocardiologywhatistheevidenceforbreastcancerasystematicreviewoftheliterature
AT xanthostheodoros reverseoncocardiologywhatistheevidenceforbreastcancerasystematicreviewoftheliterature